These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23082477)

  • 1. Serum visfatin levels in a group of Egyptian obese individuals.
    Reda R; Shehab A; Soliman D; Gabr A; Abbass A
    Egypt J Immunol; 2011; 18(1):25-32. PubMed ID: 23082477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women.
    Chen CC; Li TC; Li CI; Liu CS; Lin WY; Wu MT; Lai MM; Lin CC
    Metabolism; 2007 Sep; 56(9):1216-20. PubMed ID: 17697864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
    Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
    Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
    Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
    Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration of visfatin in obese women.
    Zahorska-Markiewicz B; Olszanecka-Glinianowicz M; Janowska J; Kocełak P; Semik-Grabarczyk E; Holecki M; Dabrowski P; Skorupa A
    Metabolism; 2007 Aug; 56(8):1131-4. PubMed ID: 17618961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated visfatin levels in obese children are related to proinflammatory factors.
    Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
    J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of a moderate hypocaloric diet on visfatin levels in morbid obese patients: relationship with insulin resistance.
    De Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Castro MJ; Romero E
    Eur Rev Med Pharmacol Sci; 2010 Dec; 14(12):1031-6. PubMed ID: 21375135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
    Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
    de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
    Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating visfatin levels in healthy preterm infants are independently associated with high-density lipoprotein cholesterol levels and dietary long-chain polyunsaturated fatty acids.
    Siahanidou T; Margeli A; Kappis A; Papassotiriou I; Mandyla H
    Metabolism; 2011 Mar; 60(3):389-93. PubMed ID: 20359723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum visfatin levels in women with polycystic ovary syndrome.
    Güdücü N; İşçi H; Görmüş U; Yiğiter AB; Dünder I
    Gynecol Endocrinol; 2012 Aug; 28(8):619-23. PubMed ID: 22313145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
    Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
    Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
    Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
    Zhang XJ; Wang Z; Li HH; Yu L; Gao S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
    Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
    Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body fat distribution has no effect on serum visfatin levels in healthy female subjects.
    Ersoy C; Sadikoglu G; Orhan H; Guclu M; Sarandol E; Akgun MD; Ozcakir A; Imamoglu S
    Cytokine; 2010 Mar; 49(3):275-8. PubMed ID: 20045351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visfatin in juvenile obesity - the effect of obesity intervention and sex.
    Krzystek-Korpacka M; Patryn E; Bednarz-Misa I; Hotowy K; Noczynska A
    Eur J Clin Invest; 2011 Dec; 41(12):1284-91. PubMed ID: 21569027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum visfatin levels and metabolic syndrome criteria in obese female subjects.
    de Luis DA; Aller R; Gonzalez Sagrado M; Conde R; Izaola O; de la Fuente B
    Diabetes Metab Res Rev; 2013 Oct; 29(7):576-81. PubMed ID: 23704051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of simvastatin treatment on plasma visfatin levels in obese women.
    Petreanu M; Eleuterio N; Bosco AA; Sandrim VC
    Gynecol Endocrinol; 2014 Aug; 30(8):577-80. PubMed ID: 24819315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.